Global Dermatophytic Onychomycosis Market Analysis, Boost Growth, Future Expectations, Key Developments and Forecast to 2025

Posted on 2019-06-27 by Mark Hub in Pharmaceuticals // 0 Comments

Albany, USA, 2019-Jun-27 — /EPR Network/ —

The market for Dermatophytic Onychomycosis is growing with the expansion of this Industry Sector Worldwide. Market Research Hub (MRH) has added a new report titled “Global Dermatophytic Onychomycosis Market Insights, Forecast to 2025” which offer details about the current trends and analysis, as well as scope for the near future. This research study also covers information about the production, consumption and market share based on different active regions. Furthermore, an anticipated growth at a double-digit CAGR for the Dermatophytic Onychomycosis sector is highlighted in the report which indicates a prosperous future.

Get Report Sample Copy@ https://www.marketresearchhub.com/enquiry.php?type=S&repid=2404803

Dermatophytic onychomycosis is a fungal infection of the nail plate, nail bed, and, in some cases, the skin surrounding the nail plate. It is caused by yeast, dermatophytes, and molds; dermatophytes account for 90% of all cases. The fungus, especially Trichophyton rubrum, Trichophyton mentagrophytes, and Epidermophyton floccosum, infects the skin, hair, or nails. It is often perceived by people to be an active and contagious infection. Onychomycosis may persist or worsen if not treated. The fungi that cause onychomycosis exist in common sites such as floors, soil, socks, and shoes. Therapies for onychomycosis include debridement and drugs. Debridement is time consuming and minimally effective in eradicating the fungal infection. Systemic drug treatment is most effective in treating onychomycosis.
Factors such as the rising prevalence of dermatophytic onychomycosis, heavy investments to develop therapies, and frequent product innovations will aid in the steady growth of this market during the forecast period. An important factor that will impel the prospects for growth in this market is the augmented focus on combination therapies. Recently, it has been observed that a combination of topical and systemic treatment increases the cure rate when compared to individual therapies. Since combination therapies have improved clinical efficiency and are more cost-effective than terbinafine, they are increasingly being preferred over individual terbinafine-based therapies as they have a higher cure rate.
The global dermatophytic onychomycosis market is intensely competitive owing to the presence of numerous small and large vendors that operate at a local or global scale. To survive and succeed in this market, the vendors enter into strategic alliances with smaller players to manufacture and market new drugs.
The Americas dominated this market and is envisaged to retain its dominating market position by the end of 2020 owing to the presence of a well-developed healthcare system
The global Dermatophytic Onychomycosis market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Dermatophytic Onychomycosis market based on company, product type, end user and key regions.

This report studies the global market size of Dermatophytic Onychomycosis in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Dermatophytic Onychomycosis in these regions.
This research report categorizes the global Dermatophytic Onychomycosis market by top players/brands, region, type and end user. This report also studies the global Dermatophytic Onychomycosis market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Anacor Pharmaceuticals
Galderma
Janssen Biotech
Novartis
Valeant Pharmaceuticals
Abeona Therapeutics
Allergan
Elorac
GlaxoSmithKline
Hexima
Hisamitsu Pharmaceutical
Mayne Pharma
MediQuest Therapeutics
Meiji Seika Pharma
Merz Pharma
Moberg Pharma
NanoBio
NovaBiotics
Nuvo Research
Pfizer
Polichem
Promius Pharma
Sanofi
Seren Pharmaceuticals
Taro Pharmaceutical
Topica Pharmaceuticals
Viamet Pharmaceuticals

Market size by Product
Oral
Topical
Market size by End User
Hospitals
Clinics and laboratories
Others

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

Browse Complete Research Report with TOC@ https://www.marketresearchhub.com/report/global-dermatophytic-onychomycosis-market-insights-forecast-to-2025-report.html

Table of Contents

1 Study Coverage
1.1 Dermatophytic Onychomycosis Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Dermatophytic Onychomycosis Market Size Growth Rate by Product
1.4.2 Oral
1.4.3 Topical
1.5 Market by End User
1.5.1 Global Dermatophytic Onychomycosis Market Size Growth Rate by End User
1.5.2 Hospitals
1.5.3 Clinics and laboratories
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Dermatophytic Onychomycosis Market Size
2.1.1 Global Dermatophytic Onychomycosis Revenue 2014-2025
2.1.2 Global Dermatophytic Onychomycosis Sales 2014-2025
2.2 Dermatophytic Onychomycosis Growth Rate by Regions
2.2.1 Global Dermatophytic Onychomycosis Sales by Regions
2.2.2 Global Dermatophytic Onychomycosis Revenue by Regions

3 Breakdown Data by Manufacturers
3.1 Dermatophytic Onychomycosis Sales by Manufacturers
3.1.1 Dermatophytic Onychomycosis Sales by Manufacturers
3.1.2 Dermatophytic Onychomycosis Sales Market Share by Manufacturers
3.1.3 Global Dermatophytic Onychomycosis Market Concentration Ratio (CR5 and HHI)
3.2 Dermatophytic Onychomycosis Revenue by Manufacturers
3.2.1 Dermatophytic Onychomycosis Revenue by Manufacturers (2014-2019)
3.2.2 Dermatophytic Onychomycosis Revenue Share by Manufacturers (2014-2019)
3.3 Dermatophytic Onychomycosis Price by Manufacturers
3.4 Dermatophytic Onychomycosis Manufacturing Base Distribution, Product Types
3.4.1 Dermatophytic Onychomycosis Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Dermatophytic Onychomycosis Product Type
3.4.3 Date of International Manufacturers Enter into Dermatophytic Onychomycosis Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

To be continue..##

Send an Enquiry@ https://www.marketresearchhub.com/enquiry.php?type=enquiry&repid=2404803

About Market Research Hub

Market Research Hub (MRH) is a next-generation reseller of research reports of different sector like pharmaceutical market research and analysis. MRH’s expansive collection of industry reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.

MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients.

Matched content

Editor’s pick